For participants who had alcohol use disorder, obesity and type 2 diabetes, the use of GLP-1 medications was linked to ...

Biotech companies are racing to find Ozempic 2.0, hoping for a slice of a multi-billion-dollar industry. A few stand-out ...

Researchers at the University of Copenhagen have identified a new drug target for weight loss that curbs appetite, boosts ...

Eli Lilly said on Wednesday its weight-loss drug helped nearly 99% of patients remain diabetes-free after three years of ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

Over the past year, the question has been coming in from everywhere – from my patients and family members, from colleagues ...

Research shows that 1 in 8 adults in the US has used one of the popular GLP-1 medications, most of them trying to manage ...

The stocks of companies that make or are developing the new class of weight-loss and diabetes-management drugs were sharply ...

In the United Kingdom, the government is hoping weight loss drugs might improve public finances, eyeing their use to help ...

The FDA has added a new warning to drugs including Ozempic and Wegovy, cautioning that patients taking the drugs may be at a ...

The weight-loss drug Ozempic can help reduce stroke patients' risk of a heart attack or death, a new study says.